BSPED2011
9 Nov 2011
16:00-17:30
Main Meeting Registration
17:30-19:00
Sanofi-Aventis Satellite Symposium
Satellite Symposium Programme (pdf)(1.18mb)”
19:00-19:45
Welcome Reception
19:45-23:45
Speakers Dinner by invitation only
Novo Nordisk
10 Nov 2011
08:50-09:00
Welcome
Chair(s): Mehul Dattani
09:00-10:30
Oral Communications 1
Chair(s): Helen Spoudea & Sabah Alvi
09:00
OC1.1
Surgical treatment of children with hyperparathyroidism: single centre experience
09:11
OC1.2
Isolation and characterisation of tumorigenic progenitors/stem cells with a stabilizing mutation in beta-catenin, in a mouse model of human adamantinomatous craniopharyngioma.
09:22
OC1.3
High likelihood of malignancy in patients presenting with a thyroid nodule
09:33
OC1.4
Growth Retardation and Severe Constipation due to the first human, dominant negative Thyroid Hormone Receptor Alpha mutation
09:44
OC1.5
DECONVOLUTION ANALYSIS OF 24H SERUM CORTISOL PROFILES INFORMS THE AMOUNT AND DISTRIBUTION OF HYDROCORTSIONE REPLACEMENT THERAPY
09:55
OC1.6
Twenty novel mutations in nicotinamide nucleotide transhydrogenase (NNT) causing FGD
10:06
OC1.7
Mild GH deficiency due to two novel homozygous mutations in the gene encoding Growth-Hormone Releasing Hormone receptor (GHRHR) in a single family
10:17
OC1.8
Mutations in PROKR2 but not PROK2 are associated with congenital hypopituitarism and septo-optic dysplasia
10:30-11:00
Coffee
11:00-12:30
Symposium 1 – Update on Adrenal Disorders
Chair(s): John Gregory
11:00
S16
Familial Glucocorticoid Deficiency: An Update
11:30
S17
Recent advances in our understanding of adrenal disease and development
12:00
S18
Health problems in Congenital Adrenal Hyperplasia – a UK perspective
12:30-14:00
Lunch
13:15-14:00
Poster Tour
14:00-15:00
Oral Communications 2 - Brief Communications
Chair(s): Wolfgang Hogler & Caroline Brain
14:00
OC2.1
Sperm cryopreservation in adolescent minors with cancer: factors predicting pre-treatment semen quality in 79 minors aged 12-18 years over 10 years
14:06
OC2.2
The assessment of bone microarchitecture by high resolution magnetic resonance imaging (micro MRI) in young adults with childhood onset disease
14:12
OC2.3
MCM4 mutation causes a novel DNA replication disorder associated with short stature and adrenal failure
14:18
OC2.4
Short Term Effects of Recombinant IGF-I therapy in children with Laron’s Syndrome.
14:24
OC2.5
A selective effect of IGFBP-3 on brain volumes in healthy children
14:30
OC2.6
What defines Vitamin D deficiency biochemically in children?
14:36
OC2.7
Selective reduction in trabecular bone mineral density during treatment for childhood acute lymphoblastic leukaemia
14:42
OC2.8
Novel SOX2 mutation: from clinical phenotype to identification of new molecular mechanisms of SOX2 action and interactions.
15:00-15:30
Tea
15:30-16:30
Symposium 2 – Pubertal Disorders
Chair(s): Mehul Dattani & Liz Crowne
15:30
S19
Novel insights into Hypogonadotrophic Hypogonadism
16:00
S20
Management of Delayed Puberty
16:45-18:00
BSPED Annual General Meeting
19:45-20:15
Pre-dinner Welcome Reception
20:15-23:45
Conference Dinner
11 Nov 2011
09:00-10:00
Symposium 3 – Novel therapies/management in Diabetes Mellitus
Chair(s): Peter Hindmarsh & James Greening
09:00
S21
Insulin resistance syndromes
09:30
S22
Use of insulin for the early treatment of Type 2 Diabetes Mellitus
10:00-10:30
BSPED Research Award winners presentation from 2010
Session head(s): Tim Cheetham
10:20-10:30
BSPED Website Launch
Session head(s): Justin Davies
10:30-11:00
Coffee
11:00-11:45
Plenary Guest Lecture: Advances in our understanding of the Genetic Causes of Obesity
Session head(s): Sadaaf Farooqi
11:45-12:30
Oral Communications 3 - Brief Communications
Chair(s): Tabitha Randell & Rakesh Amin
11:45
OC3.1
The impact of growth hormone deficiency (GHD) and growth hormone treatment (GHTx) on the cardiovascular risk in survivors of bone marrow transplantation with total body irradiation (BMT/TBI) in childhood
11:56
OC3.2
Clinical, genetic, histological and radiological heterogeneity of focal forms of congenital hyperinsulinism
12:07
OC3.3
Laparoscopic near total pancreatectomy for medically unresponsive diffuse congenital hyperinsulinism
12:18
OC3.4
The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation.
12:30-13:30
Lunch
13:30-14:15
Oral Communications 4 - Brief Communications
Chair(s): Tabitha Randell & Rakesh Amin
13:30
OC4.1
Ethnicity Rather Than Deprivation Impacts on Diabetes Control and use of Treatment Regimen
13:41
OC4.2
White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national Type 2 diabetes cohort.
13:52
OC4.3
Non-linear Dynamic Analysis of Glucose Regulation in Subjects with Type 2 Diabetes and Controls - Observed Variability and Liability (OVAL)
14:03
OC4.4
Natural history of background retinopathy in children and young people with diabetes
14:15-15:55
Symposium 4 – Insulin Resistance and Type 2 Diabetes: Novel Insights
Chair(s): David Dunger & Jeremy Kirk
14:15
S24
Islet cell transplantation: an update
14:45
S25
Immunology of Type 1 Diabetes Mellitus
15:15
S26
Update on closed loop systems for the treatment of Type 1 DM
15:55-16:00
Close of Meeting